Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Michael Whitfield
Celdara Medical, Llc, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Trustees of Dartmouth College
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution
There is the potential for the value of certain technology which has been developed in Dr. Whitfield’s lab at Dartmouth (and is now licensed to Celdara Medical) to be affected by the outcome of this work. Dr. Whitfield further has a financial interest in Celdara Medical (the prime recipient of this NIH award), which has developed and markets products and services based on the licensed technology. In light of Dr. Whitfield’s role as the subcontract PI, with oversight and supervision over aspects of the project to be conducted at Dartmouth as the subrecipient site, and his interest in the aforementioned intellectual property and financial interest in the prime recipient of funding, the Dartmouth Conflict of Interest Committee considers this to meet the criteria of an FCOI as having the potential for a direct and significant impact on the design, conduct and/or reporting of the research project.
Gene Expression Signatures to Predict Treatment Response in Systemic Sclerosis
The goal of this proposal is to validate a next generation diagnostic tool, the ScleroType test, that uses nanoString based gene expression analyses of skin to subtype scleroderma patients, and to further assess its ability to predict disease course and clinical improvement during treatment. Identification of gene expression signatures that identify patients most likely to benefit from specific therapies would provide a vast improvement to patient management by reducing exposure to side effects, reducing costs and importantly, enabling identification and selection of effective therapies for appropriate patients.
Filed on April 25, 2016.
Tell us what you know about Michael Whitfield's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Michael Whitfield”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Michael Whitfield | Dartmouth College | Conflict of Interest | Celdara Medical, LLC | $5,000 - $9,999 |
| Michael Whitfield | Celdara Medical, Llc | Conflict of Interest | Trustees of Dartmouth College | Value cannot be readily determined |
| Michael Whitfield | Dartmouth College | Conflict of Interest | Celdara Medical, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.